SOLVO and KRISHGEN BioSystems announce Distribution and Service Representation Agreement
November 08, 2007
SOLVO Biotechnology (Hungary) and KRISHGEN BioSystems (India) announce Distribution and Service Representation Agreement for SOLVO's Membrane Transporter Assay Products and Services in India, Singapore, Malaysia, Hong Kong, Thailand, Srilanka, Bangladesh, Pakistan and Nepal. Budapest, Hungary - Mumbai, India; 30th October, 2007 - SOLVO Biotechnology (SOLVO) and KRISHGEN BioSystems (KRISHGEN) announced that they have formed a partnership to distribute and represent SOLVO's leading Membrane Transporter Assay Products and Services in India. "Membrane transporters play a key role in the Absorption, Distribution, Metabolism and Excretion of drugs at the most important pharmacological barriers as well as in transporter mediated toxicity and drug-drug interactions" explained G�bor Heltovics, SOLVO's Business Development Director. "SOLVO's leading assay systems are designed to detect interaction of compounds with a wide array of membrane transporter proteins. We are very excited about the opportunity to work with KRISHGEN BioSystems. This partnership will enhance the availability of our products and services to many new customers in the Indian subcontinent that shows tremendous growth potential." About SOLVO Biotechnology: SOLVO Biotechnology - "The Transporter Company" has been the pioneer and the leader in the commercialization of Membrane Transporter technologies, including therapeutics, diagnostics and drug discovery assays. The company offers drug discovery products and services to pharmaceutical, biotechnology and consumer goods industries, relevant to many therapeutic areas and product categories. SOLVO Biotechnology provides a number of solutions for membrane transporter assays to be used in drug discovery and development: o Membrane Preparations - to be used for ATPase Assay and Vesicular Transport Assay (indirect and direct uptake) measurements; o Whole cell and Monolayer Assays; o In vivo animal testing; o Comprehensive Contract Screening Services; o Sublicense for the Calcein Assay; o Custom-Made Expression and Screening Systems. SOLVO Biotechnology has an extensive development pipeline that is expected to create a unique service platform that integrates, correlates and harmonizes DMPK and ADME-Tox in vitro, ex vivo and in vivo research systems to evaluate the membrane transporter profiles of drug candidates at various pharmacological barriers and transporter mediated drug-drug interactions. About KRISHGEN BioSystems: KRISHGEN BIOSYSTEMS is a knowledge firm providing biotech solutions to the research, diagnostic and biotech community in India. KRISHGEN has a focus on distribution and marketing with a network all across South East Asia with a major emphasis on India. SOLVO's extensive product range will contribute in offering a one-stop shop for DMPK/ADME-Tox Lab users.Next entry: SOLVO Biotechnology among the region’s fastest growing
Previous entry: SOLVO Biotechnology and tebu-bio announce Distribution and Service Representation Agreement
